Long Acting Injectables and their Correlation with Subjectivity in Schizophrenia Spectrum Disorder
- PMID: 34421142
- PMCID: PMC8374925
Long Acting Injectables and their Correlation with Subjectivity in Schizophrenia Spectrum Disorder
Abstract
Nowadays, mental illness can no longer be considered as a mere list of symptoms corresponding to localized brain dysfunctions but rather as a disturbance of the patient's subjectivity. Thus, a solid, qualitative study of patients' subjectivity could represent a useful tool in the complex evaluation of efficacy of pharmacotherapy in schizophrenic persons. In this perspective, authors performed a phenomenological oriented investigation on 49 patients, diagnosed with schizophrenia spectrum disorder, who were receiving long-acting injectable (LAI) antipsychotic therapy. From data analysis, authors found a positive correlation between general psychopathology and the use of LAI antipsychotic therapies. The present study highlighted the necessity of a careful investigation of patients' subjectivity in a phenomenological way as an irreducible part of both psychopathological and psychopharmacological matters.
Keywords: long-acting injectables; phenomenology; psychopathology; schizophrenia; subjectivity.
Copyright © 1964–2019 by MedWorks Media Inc, Los Angeles, CA All rights reserved. Printed in the United States.
Figures
References
-
- Kapur S, Mizrahi R, Li M. From dopamine to salience to psychosis – linking biology, pharmacology and phenomenology of psychosis. Schizophrenia Research. 2005:59–68. - PubMed
-
- Parnas J. Introduction to the italian translation of the EASE manual. 2009 In: Giovanni Fioriti Editore, ed. Esame Dell’Abnorme Esperienza Del Sé (EASE)
-
- Galimberti U. Karl Jaspers e la Psicopatologia. Atque. 2001;22:63–78.
-
- Fuchs T. The challenge of neuroscience: Psychiatry and phenomenology today. Psychopathology. 2002;35(6):319–326. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical